MYCOF (Mydecine Innovations Group) Construction In Progress : $0.00 Mil (As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Mydecine Innovations Group Construction In Progress?

Mydecine Innovations Group Construction In Progress Historical Data

The historical data trend for Mydecine Innovations Group's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mydecine Innovations Group Construction In Progress Chart

Mydecine Innovations Group Annual Data

Trend

Aug14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

Mydecine Innovations Group Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Construction In Progress	Get a 7-Day Free Trial															-	-	-	-	-

Mydecine Innovations Group Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Mydecine Innovations Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (OTCPK:MYCOF) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

0NF0:Germany MYCO:Canada

Address

1890 – 1075 West Georgia Street, Suite 810, Vancouver, BC, CAN, V6E 3C9

Website

https://www.mydecine.com

Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.